Avidity Partners Management LP
DALLAS, TX · CIK 1791827 · 13F filing filed 2022-08-15
SEC-registered investment adviser since 2020 · limited partnership
- Assets managed$1.1bn
- Staff9 · 7 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds3 (3 hedge) · $1.1bn gross assets
- Form ADV · 2026-03-31SEC adviser record
- Legal entityAVIDITY PARTNERS MANAGEMENT LP (US)
- Kindhedge funds
- Others nearbyDallas, TX, New York, NY
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Dallas, TX (main office)United States | about 5 |
| New York, NYUnited States | 2 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ASTRAZENECA PLC SPONSORED ADR | $231.2m5.31% | Reduced -201.0k |
| VERTEX PHARMACEUTICALS INC VRTX | $223.5m5.13% | Added +247.4k |
| ARGENX SE ARGX | $216.9m4.98% | Added +396.5k |
| ELEVANCE HEALTH INC ELV | $212.8m4.89% | Added +41.6k |
| AVANTOR INC AVTR | $206.9m4.75% | Added +984.4k |
| ELI LILLY & CO LLY | $197.8m4.54% | New |
| HUMANA INC HUM | $193.0m4.43% | Added +213.4k |
| UNITED THERAPEUTICS CORP DEL UTHR | $171.0m3.93% | Added +6.7k |
| JOHNSON & JOHNSON JNJ | $159.8m3.67% | Added +546.2k |
| HORIZON THERAPEUTICS PUB L HZNP | $148.1m3.40% | Added +725.5k |
| NEUROCRINE BIOSCIENCES INC NBIX | $143.1m3.28% | Added +307.6k |
| ARVINAS INC ARVN | $141.2m3.24% | Added +440.3k |
| SPDR SER TR XBI | $139.3m3.20% | Added +1.4m |
| MCKESSON CORP MCK | $126.8m2.91% | Added +199.3k |
| UNITEDHEALTH GROUP INC UNH | $124.4m2.86% | Reduced -17.4k |
| ABBVIE INC ABBV | $115.6m2.65% | Reduced -711.1k |
| SYNDAX PHARMACEUTICALS INC SNDX | $104.9m2.41% | Added +626.6k |
| CATALENT INC CTLT | $102.5m2.35% | Added +173.0k |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $100.8m2.31% | Added +408.9k |
| SEAGEN INC SGEN | $97.3m2.23% | Added +450.0k |
| BOSTON SCIENTIFIC CORP BSX | $94.1m2.16% | Added +1.3m |
| BIOGEN INC BIIB | $89.8m2.06% | Added +75.6k |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $88.3m2.03% | Added +610.5k |
| ACADIA HEALTHCARE COMPANY IN ACHC | $70.0m1.61% | New |
| INTELLIA THERAPEUTICS INC NTLA | $58.2m1.34% | Added +735.1k |
| LEGEND BIOTECH CORP LEGN | $55.0m1.26% | Reduced -95.0k |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $50.7m1.16% | Added +484.0k |
| IMMUNOCORE HLDGS PLC IMCR | $50.4m1.16% | Reduced -13.8k |
| NATERA INC NTRA | $48.5m1.11% | Added +69.1k |
| INTRA-CELLULAR THERAPIES INC ITCI | $44.3m1.02% | New |
| IDEAYA BIOSCIENCES INC IDYA | $41.0m0.94% | Added +282.9k |
| BELLUS HEALTH INC NEW BLU | $39.4m0.90% | Added +580.0k |
| ALTIMMUNE INC ALT | $34.9m0.80% | Added +116.0k |
| KEZAR LIFE SCIENCES INC COM | $33.5m0.77% | Added +532.0k |
| AVIDITY BIOSCIENCES INC RNA | $30.2m0.69% | Added +35.2k |
| KARUNA THERAPEUTICS INC COM | $25.9m0.59% | New |
| REVOLUTION MEDICINES INC RVMD | $25.8m0.59% | New |
| ARK ETF TR ARKG | $23.6m0.54% | New |
| VIR BIOTECHNOLOGY INC VIR | $19.3m0.44% | Reduced -21.8k |
| NKARTA INC NKTX | $17.4m0.40% | New |
| PHATHOM PHARMACEUTICALS INC PHAT | $16.2m0.37% | Reduced -26.2k |
| CARIBOU BIOSCIENCES INC CRBU | $16.0m0.37% | Added +130.9k |
| DECIPHERA PHARMACEUTICALS IN DCPH | $15.8m0.36% | New |
| NUVATION BIO INC NUVB | $15.7m0.36% | Reduced -6 |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $15.4m0.35% | Reduced -4.7m |
| XENON PHARMACEUTICALS INC XENE | $13.7m0.31% | New |
| SI-BONE INC SIBN | $13.2m0.30% | Unchanged |
| SEASPINE HLDGS CORP SPNE | $11.4m0.26% | Unchanged |
| ALPHATEC HLDGS INC ATEC | $11.2m0.26% | Reduced -1.0m |
| APELLIS PHARMACEUTICALS INC APLS | $9.7m0.22% | Added +5.0k |
| JAZZ PHARMACEUTICALS PLC JAZZ | $9.7m0.22% | New |
| ALPINE IMMUNE SCIENCES INC NVLS | $8.5m0.20% | Reduced -208.4k |
| ESSA PHARMA INC EPI | $7.7m0.18% | Unchanged |
| CENTURY THERAPEUTICS INC IPSC | $7.3m0.17% | Unchanged |
| ERASCA INC ERAS | $5.5m0.13% | Unchanged |
| CYTEIR THERAPEUTICS INC COM | $5.5m0.13% | Unchanged |
| AN2 THERAPEUTICS INC ANTX | $5.3m0.12% | Unchanged |
| COMPASS THERAPEUTICS INC CMPX | $5.3m0.12% | Unchanged |
| MEDICUS SCIENCES ACQUISITION CL A SHS | $5.1m0.12% | Unchanged |
| BCLS ACQUISITION CORP COM CL A | $5.0m0.11% | Unchanged |
| ARYA SCIENCES ACQU CORP IV CL A | $4.9m0.11% | Unchanged |
| PANACEA ACQUISITION CORP II CL A SHS | $4.9m0.11% | Unchanged |
| SENTINELONE INC S | $4.8m0.11% | Unchanged |
| IVERIC BIO INC OPHT | $4.1m0.09% | Reduced -6.0m |
| HEALTH SCIENCES ACQ CORP 2 OBIO | $4.0m0.09% | Unchanged |
| TANGO THERAPEUTICS INC TNGX | $3.7m0.08% | Added +92.6k |
| HYPERFINE INC HYPR | $3.4m0.08% | Unchanged |
| CAREMAX INC COM CL A | $2.7m0.06% | Unchanged |
| PHASEBIO PHARMACEUTICALS INC PHAS | $2.6m0.06% | Unchanged |
| FIELD TRIP HEALTH LTD COM | $2.5m0.06% | Unchanged |
| ONCOSEC MED INC COM | $2.2m0.05% | Unchanged |
| OTONOMY INC OTIC | $2.1m0.05% | Reduced -349.9k |
| SOCIAL CAP SUVRETTA HLD CRPI CLASS A ORD SHS | $2.0m0.05% | Unchanged |
| SOCIAL CAP SUVRETTA HLDS CRP CLASS A ORD SHS | $2.0m0.05% | Unchanged |
| GRAPHITE BIO INC GRPH | $2.0m0.04% | Unchanged |
| SOCIAL CAP SUVRETTA HLDS CRP CLASS A ORD SHS | $1.9m0.04% | Unchanged |
| SOCIAL CAP SUVRETTA HLDS CP CLASS A ORD SHS | $1.9m0.04% | Unchanged |
| SCYNEXIS INC COM NEW | $1.8m0.04% | Added +415.5k |
| SEMA4 HOLDINGS CORP SMFR | $1.2m0.03% | Unchanged |
| SCIENCE 37 HOLDINGS INC COM | $864.0k0.02% | Unchanged |
| NUVATION BIO INC NUVB.WS | $28.0k0.00% | Unchanged |
| MEDICUS SCIENCES ACQUISITION *W EXP 02/12/202 | $10.0k0.00% | Unchanged |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| MERCK & CO INC MRK | $194.5m2.4m shares |
| BAXTER INTL INC BAX | $148.5m1.9m shares |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $146.0m1.2m shares |
| MIRATI THERAPEUTICS INC MRTX | $114.5m1.4m shares |
| INTUITIVE SURGICAL INC ISRG | $98.0m325.0k shares |
| ADICET BIO INC | $62.3m3.1m shares |
| EDWARDS LIFESCIENCES CORP EW | $51.8m440.0k shares |
| BAUSCH HEALTH COS INC BHC | $38.7m1.7m shares |
| INSMED INC INSM | $31.8m1.4m shares |
| CHEMOCENTRYX INC CCXI | $29.5m1.2m shares |
| AXSOME THERAPEUTICS INC AXSM | $29.4m711.0k shares |
| ARCUS BIOSCIENCES INC RCUS | $28.8m912.0k shares |
| PENUMBRA INC PEN | $23.1m104.0k shares |
| VIRIDIAN THERAPEUTICS INC VRDN | $19.2m1.0m shares |
| BLUEPRINT MEDICINES CORP BPMC | $18.6m291.2k shares |
| GALAPAGOS NV LKFT | $13.3m215.0k shares |
| DYNAMICS SPECIAL PURPOSE COR | $4.9m500.0k shares |
| HELIX ACQUISITION CORP MLTX | $4.4m400.0k shares |
| GRITSTONE BIO INC GRTS | $2.3m560.0k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| IMMUNIC INC 13G · filed 2026-04-17 | 9.9% |
| CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2026-05-12 | 8.7%≈ $4.6m |
| PERSPECTIVE THERAPEUTICS INC CATX · 13G · filed 2026-03-10 | 5.3%≈ $20.6m |